Welcome to the e-CCO Library!

P0054: Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses
Year: 2025
Source: ECCO'25
Authors: Chiarax7x7x7 M.L.(1)*;Parentex7x7x7 I.A.(1);Flamminix7x7x7 L.(1);Martinax7x7x7 V.(1);Vacondiox7x7x7 F.(1);Federicax7x7x7 G.(2);de’Angelisx7x7x7 G.L.(2);Elisabettax7x7x7 B.(1);Bertonix7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0055: Impact of Indole-3-Propionic Acid on Bacterial Invasion Potential of Klebsiella Strains Isolated from Pediatric Ulcerative Colitis Patients
Year: 2025
Source: ECCO'25
Authors: Arjomand Fardx7x7x7 N.(1)*;Aujlax7x7x7 H.(2);Stuartx7x7x7 L.(1);C Chengx7x7x7 C.(2);Elhenawyx7x7x7 W.(3);Perryx7x7x7 T.(4);Winex7x7x7 E.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0056: Efficacy of Infliximab in Biologic-Experienced Patients with Inflammatory Bowel Disease: A Retrospective Study
Year: 2025
Source: ECCO'25
Authors: Borges Chavesx7x7x7 C.(1)*;Corveirax7x7x7 J.(2);Ferreirax7x7x7 A.M.(3);Lopesx7x7x7 S.(3);Mendesx7x7x7 S.(3);Ferreirax7x7x7 M.(3);Narra Figueiredox7x7x7 P.(1x7x7x72);Portelax7x7x7 F.(2x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0057: METTL3 potentiates aged CD4+T cell response via programming effector differentiation in elderly ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 Y.(1)*;Xux7x7x7 J.(1);Caox7x7x7 S.(1);Wangx7x7x7 J.(1);Linx7x7x7 Y.(1);Liux7x7x7 Y.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0058: Modulation of early innate and adaptive immune responses in primary human intestinal tissue ex vivo
Year: 2025
Source: ECCO'25
Authors: Benekex7x7x7 V.(1)*;Griegerx7x7x7 K.(1);Dehmelx7x7x7 S.(1);Neuhausx7x7x7 V.(1);Lingex7x7x7 H.(2);Kulikx7x7x7 U.(2);Aselmannx7x7x7 H.(3);Gundertx7x7x7 B.(3);Braunx7x7x7 A.(1);Hessex7x7x7 C.(1);Sewaldx7x7x7 K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0059: Mechanistic understanding of MB310: a consortium of gut commensal bacteria for the treatment of Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Schreiberx7x7x7 F.(1)*;Villeminx7x7x7 C.(1);Sharpingtonx7x7x7 T.(2);Lawleyx7x7x7 T.D.(2x7x7x73);Robinson x7x7x7 M.J.(4);Bakdashx7x7x7 G.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P005: A multi-marker serum test to assess the presence of ulcerations in infliximab treated patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. de Bruyn1,2*, T. Bessissow3, V. Kondragunta4, A. Jain4, I. Arijs5, G. Van Assche1,6, M. Ferrante1,6, G. Opdenakker2, S. Vermeire1,6

Created: Thursday, 21 February 2019, 9:14 AM
P005: Cytokine mediated intercellular communication in inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Thomas, J.P.(1,2,3);Olbei, M.(2,3);Hautefort, I.(2);Modos, D.(2,3);Korcsmaros, T.(2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P005: Establishing a porcine model to translate anorectal stem cell organoid models to elucidate the aetiology of perianal Crohn's fistulae
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Adegbola S.*1, Moore J.2, Sahnan K.1, Tozer P.1, Phillips R.1, Warusavitarne J.3, Faiz O.1, Hart A.4

Created: Wednesday, 20 February 2019, 10:36 AM
P005: Molecular-based classification of ulcerative colitis and its dynamic
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Seyed Tabib, N.S.(1)*;Verstockt, S.(1);Verstockt, B.(1,2);Ferrante, M.(1,2);Sabino, J.(1,2);Vermeire, S.(1,2);
Created: Friday, 14 July 2023, 10:43 AM
P005: Persistent transcriptional reprogramming in the choroid plexus during chronic colitis: towards understanding persistent fatigue in patients with quiescent inflammatory bowel disease?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Bruggeman1,2, C. Vandendriessche1,2, M. De Vos3,4, R. Vandenbroucke1,2, D. Laukens*3,4

Created: Friday, 22 February 2019, 9:41 AM
P005: The solute carrier LC22A4/Organic Cation Transporter (OCTN)-1 as a novel Inflammatory Bowel Disease determinant at the microbe-host interface.
Year: 2022
Source: ECCO'22
Authors: Masi, L.(1);Petito, V.(1);Fidaleo, M.(2);Palucci, I.(3);Del Chierico, F.(4);Ivagnes, V.(3);Mercuri, A.(5);Graziani, C.(1);Lopetuso, L.R.(1);Armuzzi, A.(1);Gasbarrini, A.(1);Pani, G.(5);Scaldaferri, F.(1);
Created: Friday, 11 February 2022, 3:52 PM
P005: Variability in Vedolizumab Exposure between Patients with Inflammatory Bowel Disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Gils1, E. Dreesen*1, M. Peeters1, E. Brouwers1, M. Ferrante2, G. Van Assche2, S. Vermeire2

Created: Friday, 22 February 2019, 9:49 AM
P006 3D Multicellular intestine-on-a-chip model for disease modelling and drug discovery
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Lo Sasso1, L. Gijzen2, D. Marescotti1, E. Naumovska2, E. Raineri2, A. Nicolas2, H. Lanz2, D. Guerrera1, R. van Vught2, J. Joore2, P. Vulto2, M.C. Peitsch1, J. Hoeng1, D. Kurek2

Created: Thursday, 30 January 2020, 10:12 AM
P0060: GPR15L counteracts chronic colitis by shaping the intestinal microbiota
Year: 2025
Source: ECCO'25
Authors: Leggiox7x7x7 M.(1);Schrammx7x7x7 S.(1);Ocónx7x7x7 B.(2);Wirtzx7x7x7 S.(1);Puertolas Balintx7x7x7 F.(3);Dietzx7x7x7 L.(1);Schröderx7x7x7 B.(3);Butcherx7x7x7 E.(2);Müllerx7x7x7 T.(1);Neurathx7x7x7 M.F.(1);Zundlerx7x7x7 S.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0061: Guselkumab induction therapy results in molecular resolution of inflammation in moderately to severely active Ulcerative Colitis: results from the Phase 3 QUASAR induction study
Year: 2025
Source: ECCO'25
Authors: Sridharx7x7x7 S.(1)*;Hartx7x7x7 A.(1);Venkatx7x7x7 S.(1);Huangx7x7x7 K.H.G.(1);Yarandix7x7x7 S.(1);Germinarox7x7x7 M.(1);Vetterx7x7x7 M.(1);Rubinx7x7x7 D.T.(2);Dignassx7x7x7 A.(3);Cuax7x7x7 D.(1);Freemanx7x7x7 T.(1);Waterworthx7x7x7 D.(1);McRaex7x7x7 B.(1);Verstocktx7x7x7 B.(4);Braniganx7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0062: Circulating immune cell populations as predictive markers of vedolizumab response in Crohn disease
Year: 2025
Source: ECCO'25
Authors: Soletox7x7x7 I.(1)*;González-de Castrox7x7x7 C.(2); Arribasx7x7x7 E.(3);Ramirezx7x7x7 C.(4);Baldan-Martinx7x7x7 M.(4); Riestrax7x7x7 S.(5); Lucendox7x7x7 A.J.(6); Garcíax7x7x7 M.J.(7); Martín-Arranzx7x7x7 E.(8);De Pradox7x7x7 Á.(3);Casanovax7x7x7 M.J.(4);Chaparrox7x7x7 M.(4);Bernardo*x7x7x7 D.(3);Gisbert*x7x7x7 J.P.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0063: Prevalence of sarcopenia in a cohort of patients with inflammatory bowel disease: observational study in a tertiary care centre
Year: 2025
Source: ECCO'25
Authors: Palmisanox7x7x7 C.M.(1)*;Dell'Aquilax7x7x7 P.(2);Cormiox7x7x7 S.(3);Boraccinox7x7x7 V.(4);Noviellix7x7x7 D.(4);Savinox7x7x7 F.(4);Squeox7x7x7 F.(4);Forastierex7x7x7 D.(4);Moschettax7x7x7 A.(5);Principix7x7x7 M.R.D.(6);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0064: Investigating a pathogenic role for IL-18 in Inflammatory Bowel Disease beyond the classical type 1 immunity paradigm
Year: 2025
Source: ECCO'25
Authors: Grillmaierx7x7x7 M.(1)*;Barendregtx7x7x7 D.(1);Caladox7x7x7 B.(1);Herediax7x7x7 M.(1);Smitsx7x7x7 W.(1);Tukx7x7x7 B.(1);van Berkelx7x7x7 L.(1);Hulleman-van Haaftenx7x7x7 D.(1);Klombergx7x7x7 R.(2);Vuijkx7x7x7 S.(2);Cammanx7x7x7 A.(2);Doukasx7x7x7 M.(3);de Ridderx7x7x7 L.(2);Escherx7x7x7 J.(2);Samsomx7x7x7 J.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0065: Circulating cell-free DNA and mitochondrial DNA differentiate disease activity in paediatric-onset inflammatory bowel disease: Interim analysis from Scotland-wide Mini-MUSIC study (2020-26)
Year: 2025
Source: ECCO'25
Authors: Wandsx7x7x7 D.(1x7x7x72x7x7x73)*;Laux7x7x7 S.Y.(2);Chuahx7x7x7 C.S.(2);Hallx7x7x7 R.(2);Whelanx7x7x7 R.(2);Fischerx7x7x7 L.(2);Kallax7x7x7 R.(2);Cartlidgex7x7x7 P.(2);Druryx7x7x7 B.(2);Chalmersx7x7x7 I.(4);Hansenx7x7x7 R.(5);Wilsonx7x7x7 M.(3);Jonesx7x7x7 G.(2);Wilsonx7x7x7 D.(3);Hox7x7x7 G.T.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session